CellVax Therapeutics is a privately-held clinical-stage company developing autologous anticancer vaccines
CellVax Therapeutics Inc. has raised $2.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.
CellVax Therapeutics Inc. is headquartered in Miami, United States.
CellVax Therapeutics is a privately-held clinical-stage company developing autologous anticancer vaccines
CellVax Therapeutics Inc. is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CellVax Therapeutics Inc. — Funding & Investors." VCBacked, October 4, 2024, https://www.vcbacked.co/company/cellvax-therapeutics-inc. Accessed August 15, 2026.
VCBacked. (2024). CellVax Therapeutics Inc. — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cellvax-therapeutics-inc
{{cite web |title=CellVax Therapeutics Inc. — Funding & Investors |url=https://www.vcbacked.co/company/cellvax-therapeutics-inc |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated